Ayble Health raised a $16 million Series A led by Neon to expand its virtual digestive and autoimmune healthcare services.
- Amount
- $16M
- Stage
- Series A
- Announced
- 16 September 2026
- Lead
- Neon
- Other investors
- Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice
- Use of funds
- Advance proprietary AI+clinician precision care model and expand into autoimmune conditions.
- Total raised
- $27M to date
- Checked
- Announced by the company